Suppr超能文献

术中化学髓核溶解术作为腰椎间盘切除术的辅助手段。

Intraoperative chemonucleolysis as an adjunct to lumbar discectomy.

作者信息

Sagher O, Szabo T A, Chenelle A G, Jane J A

机构信息

Section of Neurosurgery, University of Michigan Medical Center, USA.

出版信息

Spine (Phila Pa 1976). 1995 Sep 1;20(17):1923-7. doi: 10.1097/00007632-199509000-00015.

Abstract

STUDY DESIGN

This is a report of a series of 104 patients who underwent lumbar discectomy and chemonucleolysis at the University of Virginia between 1985 and 1989.

OBJECTIVE

The primary objective was to determine the safety of this procedure. A secondary objective was to begin studying its efficacy.

SUMMARY OF BACKGROUND DATA

This is the first report on the use of chymopapain during open surgery.

METHODS

Patients with low back pain and radicular symptoms not cured with conservative therapy were selected for participation in the study. Intraoperatively, disc spaces were injected with 2 ml of chymopapain. Patients were followed-up for an average of 5 years. Patients were surveyed regarding pain relief, and failures of the procedure were analyzed.

RESULTS

Seventy percent of patients reported good or excellent pain relief. Operative failures, characterized by reoperation at the same level, totaled 9.6%. Recurrent disc herniation at the time of reoperation occurred in 4.8%.

CONCLUSION

The procedure is safe and the relief of pain was similar to that in other published series. The suggestion is that the rate of recurrent disc herniation is reduced.

摘要

研究设计

这是一份关于1985年至1989年间在弗吉尼亚大学接受腰椎间盘切除术和化学髓核溶解术的104例患者的系列报告。

目的

主要目的是确定该手术的安全性。次要目的是开始研究其疗效。

背景资料总结

这是关于在开放手术中使用木瓜凝乳蛋白酶的首份报告。

方法

选择经保守治疗未治愈的腰痛和神经根症状患者参与研究。术中,向椎间盘间隙注射2毫升木瓜凝乳蛋白酶。对患者平均随访5年。就疼痛缓解情况对患者进行调查,并分析手术失败情况。

结果

70%的患者报告疼痛缓解良好或极佳。以同一节段再次手术为特征的手术失败率总计为9.6%。再次手术时复发性椎间盘突出的发生率为4.8%。

结论

该手术安全,疼痛缓解情况与其他已发表系列研究相似。提示复发性椎间盘突出率降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验